Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
Holding SUPN?
Track your performance easily

Supernus Pharmaceuticals (SUPN) Balance Sheet

476 Followers

Supernus Pharmaceuticals Balance Sheet

Supernus Pharmaceuticals's total assets for Q2 2024 were $1.32B, an increase of 0.90% from the previous quarter. SUPN total liabilities were $358.38M for the fiscal quarter, a -4.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 1.28B$ 1.70B$ 1.69B$ 1.50B$ 1.16B
Total Liabilities
$ 356.16M$ 816.30M$ 873.30M$ 759.24M$ 564.85M
Total Equity Gross Minority
$ 921.52M$ 886.20M$ 815.85M$ 744.86M$ 595.43M
Total Capitalization
$ 954.71M$ 922.20M$ 1.20B$ 1.11B$ 940.60M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 52.57M$ 33.27M
Currency in USD

Supernus Pharmaceuticals Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis